GNA Biosolutions is a private molecular diagnostics company.
GNA Biosolutions is a molecular technology company based in Martinsried, Germany. Their breakthrough technology, Pulse Controlled Amplification, transforms molecular testing by combining ultrafast nucleic acid amplification with intrinsic sample prep, to enable powerful solutions for the laboratory, on-site applications and the Point of Care. Their vision is to bring the power of molecular testing, from sample to answer, to everyone, everywhere.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 6, 2019 | Series C | $13.50M | 9 | GreyBird Ventures | — | Detail |
Mar 7, 2015 | Series B | €6M | 6 | — | — | Detail |
Mar 14, 2011 | Series A | — | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
GreyBird Ventures | Yes | Series C |
btov Partners | — | Series C |
Robert Bosch Venture Capital | — | Series C |
KfW | — | Series C |
Mey Capital Matrix | — | Series C |
OCCIDENT | — | Series C |
SHS Capital | — | Series C |
UVC Partners | — | Series C |
Wachstumsfonds Bayern | — | Series C |